Prof. Dr. Christoph Hock
Prof. Dr. med. Christoph Hock studied medicine at LMU Munich (Ludwig-Maximilians Universität München) and earned his doctoral degree at the Max Planck Institute of Psychiatry in Munich/Martinsried. His career path led him to positions as attending physician and head of diverse research groups at the psychiatric hospital at the University of Basel before he was appointed associate professor of biological psychiatry at the University of Zurich in 2001. In 2007, he was named full professor. In 2016, Professor Hock took on the position of Director of the Institute for Regenerative Medicine at the Schlieren Campus of the University of Zurich.
Christoph Hock’s main areas of research include diagnostic and clinical therapeutic studies on Alzheimer's disease; distinctions awarded include the research prize of the Swiss Alzheimer's association in 2004, the Doron Prize in 2006, and the ZKB Technopark Pioneer Award in 2010. He is co-founder of numerous UZH spin-off companies, including Neurimmune Holding Ltd., a company specialized in developing innovative immunotherapeutics for neurodegenerative diseases.